Litteratur
Här följer ett urval översikter och artiklar. En utförlig
litteraturförteckning kan erhållas frånförfattarna.
GH
Isaksson OGP, Jansson JO, Gause
I.
Growth hormone
stimulates bone directly. Science 1982;216:1237-9.
CorpasE,HarmanSM,BlackmanMR. Humangrowth
hormone and aging [Review]. Endocr Rev 1993;14:20-
39.
Inzucchi SE, Robbins RJ. Effects ofgrowth hormone
on human bone biology [Review]. J Clin Endocrinol
Metab 1994;79:691-44.
De Boer H, Blok G-J, Van der Veen EA. Clinical
aspects of growth horrnone deficiency in adults [Re–
view]. Endocr Rev 1995;16:63-86.
HO KKY, Hoffman DM. Defining growth horrnone
deficiency in adults. Metabolism 1995;44:91-6.
IGF och IGFBP
Clemmons DR, Jones
JI,
BusbyWH,Wright G. Role of
insulin-like growth factor bindingproteins inmodifying
IGF actions. Ann NYAcad Sci 1993;692:10-21.
LangfordKS,Miell JP. The insulin-likegrowth factor–
l/bindingprotein axis: physiology, pathophysiology and
therapenticmanipulation. E
ur
JClin Invest 1993;23:503-
16.
RosenCJ,DonahueLR,HunterSJ. Insulin-likegrowth
factors and bone: the osteoporosis connection [Review].
Proc Soc Exp Bio! Med 1994;206:83-102.
Landin-Wilhelmsen K, Wilhelmsen L, Lappas G,
Rosen T, Lindstedt G, Lundberg P-A, Bengtsson B-Å.
Serum insulin-like growth factor I in a random po–
pulation sample ofmen and women: relationship to age,
sex, smoking habits, coffee consumptian and physical
activity, blood pressure and concentrations of plasma
lipids, fibrinogen, parathyroidhormone andosteocalcin.
Clin Endocrinol (Oxf) 1994;41:351-7.
Klinisk Kemi
i
Norde'1
/,
1997
BaxterRC. Insulin-likegrowth factorbindingproteins
as glucoregulators. Metabolism 1995;44 (suppl 4):12-7.
GiudiceLC. IGFbindingprotein-3protease regulation:
how sweet it is! J ClinEndocrinolMetab 1995;80:2279-
81.
Jones
Jl,
Clemmons DR. Insulin-like growth factors
and their binding proteins: biologica1 actions. Endocr
Rev 1995;16:3-34.
Ketelslegers J-M,MaiterD,MaesM, UnderwoodLE,
ThissenJ-P.Nutritional regulatianofinsulin-likegrowth
factor-LMetabolism 1995;44 (suppl4):50-7.
Juul A, Dalgaard P, Blum WF, Bang P, Hall K,
MichaelsenKF,MUller J, SkakkebaekNE. Serum levels
of insulin-like growth factor (IGF)-binding protein-3
(IGFBP-3) in hea1thy infants, children, and adolescents:
the relation to IGF-I, IGF-ll, IGFBP-1, IGFBP-2, age,
sex, body mass index, and pubertal maturation.
J
Clin
Endocrinol Metab 1995;80:2534-42.
Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G,
Woitge HW, BlumWF,WUster C, HaackD, Ziegler R.
Relationship between circulating insulin-like growth
factor components and sex hormones in a population–
hased sample of 50- to 80-year-old men and women. J
Clin Endocrinol Metab 1996;81:2534-40.
Mätning av IGF och IGFBP
BlumWF,BreierBH. Radioimmunoassays for IGFs and
IGFBPs. Growth Regulation 1994;4(suppl l): 11-9.
Holly JMP, Martin JL. Insulin-like growth factor
bindingproteins: A review ofmethodological aspects of
their purification, analysis and regulation. Growth
Regulation 1994;4(suppl1):20-30.
Bang P. Insulin-like growth factor (IGF)- l and IGF
binding proteins: serum concentrations, bioavailability
andeffects ofproteases [Thesis]. Stockholm: Karolinska
Institutet 1994:1-71.
Frystyk J, Skjaerbaeck C, Dinesen B, et al. Free
insulin-like growth factors (IGF-I and IGF-II) in human
serum. FEBS Lett 1994;348:185-91.
19
